MCQs

Non-competitive inhibitors bind at sites other than the active site and can bind regardless of substrate occupancy. Competitive inhibitors require access to the active site. Concept tested: Binding characteristics of inhibitors.

Reversible inhibitors bind through weak interactions and can dissociate from the enzyme, restoring activity. Permanent destruction occurs only with irreversible inhibitors. Concept tested: Reversible inhibition.

Since excess substrate cannot overcome non-competitive inhibition, enzyme activity remains reduced. Competitive inhibition would be reversed by increasing substrate concentration. Concept tested: Differentiating inhibitor types.

Drugs are designed to inhibit specific target enzymes while minimizing effects on normal cellular metabolism. Concept tested: Therapeutic significance of enzyme inhibitors.

Mercury forms stable bonds with sulfhydryl (-SH) groups in enzymes, causing irreversible inhibition and loss of enzyme activity. Concept tested: Heavy metal inhibition.

Toxic substances such as certain heavy metals irreversibly inhibit enzymes, causing long-lasting or permanent loss of function. Concept tested: Toxicological effects of enzyme inhibitors.

Binding at an allosteric site changes the enzyme's conformation, altering the active site's ability to bind substrate effectively. The other options are incorrect. Concept tested: Allosteric inhibition.

Competitive inhibitors compete directly with the substrate for the active site, reducing substrate binding. They do not affect enzyme synthesis or ATP production. Concept tested: Mechanism of competitive inhibition.

Many antibiotics selectively inhibit bacterial enzymes required for vital metabolic pathways. They do not work by activating enzymes or universally destroying DNA. Concept tested: Medical application of enzyme inhibitors.

Competitive inhibitors closely resemble the substrate, allowing them to occupy the enzyme's active site. Similarity to products or coenzymes is not responsible for competitive inhibition. Concept tested: Structure-function relationship.

Enzyme inhibitors regulate metabolic pathways, preventing excessive or unnecessary reactions and maintaining homeostasis. The other options have no physiological basis. Concept tested: Metabolic regulation.

A non-competitive inhibitor lowers the maximum reaction rate regardless of substrate concentration because it alters enzyme structure. Competitive inhibition can be overcome by excess substrate. Concept tested: Interpretation of enzyme kinetics.

Irreversible inhibitors permanently inactivate enzyme molecules. Cells regain activity only by producing new enzymes. Extra substrate cannot restore function. Concept tested: Consequences of irreversible inhibition.

Reversible inhibitors regulate metabolic pathways according to cellular needs. Permanent inactivation is characteristic of irreversible inhibitors rather than reversible regulation. Concept tested: Physiological regulation.

Increasing substrate concentration increases the likelihood of substrate binding instead of inhibitor binding, restoring enzyme activity. The remaining options are biologically incorrect. Concept tested: Reversibility of competitive inhibition.

Heavy metals such as lead commonly inhibit enzymes by binding strongly to functional groups, causing irreversible loss of activity. They neither serve as coenzymes nor enhance enzyme synthesis. Concept tested: Heavy metal inhibition.

Non-competitive inhibitors bind at an allosteric site and alter the enzyme's three-dimensional shape, reducing catalytic efficiency. They do not necessarily destroy the substrate or all proteins. Concept tested: Mechanism of non-competitive inhibition.

Competitive inhibitors resemble the substrate and compete for the enzyme's active site. Allosteric sites are involved in non-competitive inhibition, while coenzymes and products are not the primary binding sites for competitive inhibitors. Concept tested: Active site specificity.

Many medicines work by selectively inhibiting enzymes. Examples include drugs that inhibit bacterial enzymes or enzymes involved in cholesterol synthesis. The remaining options are biologically incorrect. Concept tested: Medical application of enzyme inhibitors.